Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Dr. Liangzhi Xie
|
| gptkbp:foundedYear |
2007
|
| gptkbp:founder |
Dr. Liangzhi Xie
|
| gptkbp:headquartersLocation |
gptkb:Beijing,_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sino Biological
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:numberOfEmployees |
over 800
|
| gptkbp:offersProduct |
ELISA kits
custom antibody production COVID-19 research reagents protein expression services |
| gptkbp:officeLocation |
gptkb:Wayne,_Pennsylvania,_USA
gptkb:Beijing,_China gptkb:Frankfurt,_Germany |
| gptkbp:servesIndustry |
life sciences
diagnostics pharmaceutical research |
| gptkbp:specializesIn |
antibodies
assay kits recombinant proteins cDNA clones |
| gptkbp:stockExchange |
gptkb:Shenzhen_Stock_Exchange
|
| gptkbp:stockSymbol |
301047
|
| gptkbp:subsidiary |
Sino Biological Europe GmbH
Sino Biological US Inc. |
| gptkbp:website |
https://www.sinobiological.com/
|
| gptkbp:bfsParent |
gptkb:Antibody_Discovery_Services
gptkb:Yizhuang_Development_Area |
| gptkbp:bfsLayer |
8
|